NCT05674513View on ClinicalTrials.gov

Disparities in Emergency Contraceptive Metabolism Dictate Efficacy

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Contraceptive Usage
Interventions
DRUG

Ulipristal acetate

Evaluating the pharmacodynamic and pharmacokinetic outcomes after 1 dose of Ulipristal acetate 30mg in individuals with and without active CYP3A5 alleles

Trial Locations (1)

97239

RECRUITING

OHSU, Portland

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Oregon Health and Science University

OTHER